Key result
Cardiac-specific deletion of Kindlin-2 in mice led to the development of hypertrophic cardiomyopathy, which was accelerated by isoproterenol treatment, through the reactivation of the transcription factor GATA4.
Why the study?
Although Kindlin-2 depletion contributes to cardiac hypertrophy and progressive heart failure, the precise mechanisms involved remain unclear.
p-value: p=<0.05
Kindlin-2 protects against pathological cardiac hypertrophy by suppressing GATA4 expression via SUV39H1-mediated histone H3K9 methylation.
Hypothesis-generating in mice; leaves open whether Kindlin-2/GATA4 targeting could modulate human hypertrophic cardiomyopathy.
Kindlin-2 plays an important role in the regulation of cardiac structure and function. Depletion of Kindlin-2 contributes to cardiac hypertrophy and progressive heart failure, however, the precise mechanisms involved in this process remain unclear. GATA4 is a critical transcription factor in regulating cardiogenesis. We found that Kindlin-2 suppresses the expression of GATA4 through binding to its promoter and prevents cardiomyocytes from hypertrophy induced by isoproterenol (ISO) treatment. Mechanistically, Kindlin-2 interacts with histone methyltransferase SUV39H1 and recruits it to GATA4 promoter leading to the occupancy of histone H3K9 di- and tri-methylation. Furthermore, to confirm the function of Kindlin-2 in vivo, we generated mice with targeted deletion of cardiac Kindlin-2. We found that 6-month-old Kindlin-2 cKO mice have developed hypertrophic cardiomyopathy and that this pathological process can be accelerated by ISO-treatment. GATA4 expression was markedly activated in cardiac tissues of Kindlin-2 cKO mice compared to wild-type animals. Collectively, our data revealed that Kindlin-2 suppresses GATA4 expression by triggering histone H3K9 methylation in part and protects heart from pathological hypertrophy.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2019) studied Cardiac hypertrophy. Cardiac-specific Kindlin-2 deletion vs. Wild-type mice was evaluated on Development of hypertrophic cardiomyopathy (assessed by heart weight to body weight ratio, cardiomyocyte size, and echocardiography) (p=<0.05). Cardiac-specific deletion of Kindlin-2 in mice led to the development of hypertrophic cardiomyopathy, which was accelerated by isoproterenol treatment, through the reactivation of the transcription factor GATA4.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: